Skip to main content
. 2018 Apr 13;18:40. doi: 10.1186/s12883-018-1037-0

Table 1.

Baseline and outcome parameters

Baseline parameter Blood parameter Neurological assessment NCSf Parameter Subjective Score
Week 0 Age
Gender
Weight
Size
Comorbidity
Medication
Duration of disease (Diabetes and DPN)
HbA1ca Clinical examination
NSS
NDSc
Bilateral amplitudes and NCVbof nn. surales and tibiales NRSd
Week 6 Clinical examination
NSSe
NDS
Bilateral amplitudes and NCV of nn. surales and tibiales NRS
Week 15 Change of medication HbA1c Clinical examination
NSS
NDS
Bilateral amplitudes and NCV of nn. surales and tibiales NRS
Adverse events
Weekly (treatment 1–10) Change of medication NRS
Adverse events

aHbA1c= glycated hemoglobin; bNCV = nerve conduction velocity; cNDS = neuropathy deficit score; dNRS = numeric rating scale; eNSS = neuropathy symptom score; fNCS = nerve conduction studies